Udayavni Special

Dr Reddy’s, RDIF get DCGI nod for clinical trial of COVID-19 vaccine Sputnik V in India


Team Udayavani, Oct 17, 2020, 6:06 PM IST

Image credits: RDIF

New Delhi: Dr Reddy”s Laboratories on Saturday said it along with Russian Direct Investment Fund (RDIF) has received approval from the Drug Control General of India (DCGI) to conduct phase 2/3 human clinical trials for COVID-19 vaccine Sputnik V in India. This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity check, the Hyderabad-based drug major said in a statement.

“This is a significant development that allows us to commence the clinical trial in India and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic,” Dr Reddy’s Laboratories Co-chairman and Managing Director G V Prasad said.

RDIF CEO Kirill Dmitriev said the entity was pleased to collaborate with the Indian regulators. “In addition to Indian clinical trial data, we will provide safety and immunogenicity study from the Russian phase 3 clinical trial. This data will further strengthen the clinical development of Sputnik V vaccine in India,” he added.

Last month, Dr Reddy’s and RDIF (Russian sovereign wealth fund) had entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr Reddy’s upon regulatory approval in the country.

On August 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against COVID-19 based on the human adenoviral vectors platform.

Sputnik V is currently undergoing phase 3 clinical trials in Russia and the proposed number of subjects is 40,000. Additionally, phase 3 clinical trial of the vaccine has commenced in the UAE last week.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

‘I am not afraid of resigning’: Punjab CM attacks Centre on farm laws issue

PM Narendra Modi to share message with nation at 6 pm today

In London with consent of my parents, there is no family rift or problems with coach: Sindhu

Two held for bomb threat to NDPS judge in Karnataka

‘Your life is in your hand’: City bus owner campaigns against drug abuse

HC stays work on Jesus Christ statue at Kapalabetta

New COVID-19 cases in India dip below 50,000 for first time in nearly three months



Related Articles More

India records 46,790 new COVID-19 cases

Bengaluru: 73% rise in COVID-19 testing capacity, reduction in mortality rate

K’taka COVID-19 update: 5018 new cases, 8005 discharges, 64 deaths on Oct 18

COVID-19: DCM Karjol’s son airlifted to Hyderabad; Pejawar seer wishes speedy recovery

14-year-old Indian-American wins USD 25,000 for work on potential COVID-19 treatment

MUST WATCH

Bantwal MLA Rajesh Naik responds to illegal quarrying allegations

Farmer turns barren land into lush green paddy field

Benefits of integrated farming system | Agriculture Insights | Udayavani

Govt will intervenes if controversy over Sigandur Temple is not resolved

How to Prepare Natural Homemade Mosquito Repellent Dhoopa by using Cow Dung | Udayavani

Latest Additions

‘I am not afraid of resigning’: Punjab CM attacks Centre on farm laws issue

Hindu groups seek apology from Kamala Harris’ niece for tweeting image depicting aunt as Durga

Twitter India launches emoji to mark 25 years of ‘Dilwale Dulhania Le Jayenge’

Lawsuit challenges Trump administration’s new H-1B visa rules

PM Narendra Modi to share message with nation at 6 pm today

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.